Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Titel:
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Auteur:
Albiges, Laurence Gurney, Howard Atduev, Vagif Suarez, Cristina Climent, Miguel A Pook, David Tomczak, Piotr Barthelemy, Philippe Lee, Jae Lyun Stus, Viktor Ferguson, Thomas Wiechno, Pawel Gokmen, Erhan Lacombe, Louis Gedye, Craig Perini, Rodolfo F Sharma, Manish Peng, Xiang Lee, Chung-Han